ExpoSignalz and Policy

ExpoSignalz is investigating the effects of chemical pollutants on neurodegenerative diseases. We hope that our research will help reduce or delay the incidence of Alzheimer’s disease, thereby alleviating the economic and social challenges linked to the condition.

Research findings will be translated into policy-relevant material. One key output is to provide evidence-based guidelines on regulating emerging pollutants and on updating regulatory dose limits for the general population and at-risk groups. We will provide recommendations for prevention strategies at both the personal and systemic levels.

ExpoSignalz is also one of seven projects that make up the ExpoHealthNet Cluster. By working together and sharing knowledge, the projects will enhance the impact of their research into environmental pollution and help to inform future policy in Europe.

How will ExpoSignalz engage with policymakers?

The project is committed to working collaboratively with policymakers and key stakeholders throughout the project by providing opportunities to inform the research activity and facilitating the exchange of knowledge. One way we are doing this is by establishing a Policy Advisory Panel to support the development of the guidelines on pollutants.

The panel will include a broad range of external experts (5-6 members), including those knowledgeable about Alzheimer’s/neurodegenerative disease and environmental pollutants, alongside members of the project team. The panel is expected to be in place by Autumn 2026.

We will organise at least two in-person policy engagement workshops to stimulate dialogue/input from policymakers and citizens (via patient groups). The first of these will be held in 2027.

ExpoHealthNet has also committed to producing three joint policy briefs, one in 2026, one in 2028, and one in 2029.

What are the benefits for policymakers in engaging with the project?

Benefits may include:

• Developing close relationships between policymakers and leading researchers and scientists, potentially leading to future projects and innovation.
• Having access to emerging academic research within the fields of the environment and brain health.
• Providing opportunities to feed into the wider ExpoHealthNet cluster and influence EU regulations and policies.
• Helping shape cutting-edge research and turning it into meaningful change across Europe.

Find out more about the expected impacts of the project.

To be kept informed of the latest developments, including publication of the policy briefings,
sign up to receive the ExpoHealthNet newsletter.